跳至主要内容
临床试验/NCT01284972
NCT01284972已完成不适用

Short to Mid Term Follow-up of Patient Implanted With the HINTEGRA® Total Ankle Prosthesis

Integra LifeSciences Services6 个研究点 分布在 6 个国家目标入组 225 人开始时间: 2009年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
225
试验地点
6
主要终点
rate of device related complications at the follow up after 2 years of implantation

研究概览

简要总结

The Hintegra® Total Ankle Prosthesis is a non constrained, three-component prosthesis that consists of a flat tibial component, an anatomically-shaped talar component, and a high-density polyethylene inlay. The Hintegra ankle was specifically developed as an attempt to address the needs of minimal bone resection, extended bone support, proper ligament balancing, and minimal contact stressed within and around the prosthesis.

The objective of this study is to evaluate the safety and efficacy of the HINTEGRA® Total Ankle prosthesis at short and mid term follow up.

研究设计

研究类型
Observational
观察模型
Case Only

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient implanted with an Hintegra® Total Ankle Prosthesis (only prosthesis designed with pegs) in primary ankle surgery since a minimum of 2 years
  • Age ≥ 18 years
  • Have willingness to give his/her data transfer authorisation

排除标准

  • History of prior mental illness or patient demonstrates that their mental capacity may interfere with their ability to follow the study protocol

结局指标

主要结局

rate of device related complications at the follow up after 2 years of implantation

时间窗: more than 2 years after the implantation

次要结局

  • AOFAS Ankle-Hindfoot Scale score (American Orthopaedic Foot and Ankle Society).(more than 2 years after the implantation)

研究者

发起方
Integra LifeSciences Services
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验